Actively Recruiting
Study Evaluating Safety and Effectiveness of Pulmonary Neuromodulation Using Spinal Cord Stimulation for Moderate to Severe Uncontrolled Asthma
Led by Spiro Medical, Inc. · Updated on 2026-10-13
30
Participants Needed
3
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety and effectiveness of Pulmonary Neuromodulation PNM for people with moderate to severe uncontrolled asthma. This study is a prospective, randomized, controlled, multi-center delayed activation feasibility trial conducted at several U.S. sites. The aim is to understand how PNM impacts asthma symptoms and quality of life over time. Participants receive a full Spinal Cord Stimulation implant on Day 0. In one group, the therapy is activated immediately, while in the other, activation is delayed until Day 90. Safety and effectiveness are assessed at multiple time points including 2 weeks, 1 month, 3 months, and continuing through 6 months after implantation. During the study, participants will have scheduled visits for evaluations at 2 weeks, 1 month, 3 months, 4 months, 5 months, and 6 months. Researchers will measure asthma control using the ACT score and quality of life through a related questionnaire. The total participation time lasts about 6 months, with safety and efficacy closely monitored throughout the study period.
CONDITIONS
Brief Title
PULmonary Stimulation for Asthma Relief
Research Team
K
Kurt Gehlsen, MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here